Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma
ACTIVE_NOT_RECRUITING
Status
Conditions
- Primary Mediastinal B-cell Lymphoma
Interventions
- OTHER: observation
- RADIATION: 3D-Conformal Radiotherapy (3D-CRT)
Sponsor
International Extranodal Lymphoma Study Group (IELSG)